Attenuation-corrected 99mtc-mibi spect in overweight patients with chronic ischaemic dysfunction: a comparison to nh3 pet and implications for the diagnosis of myocardial viability

Nuclear Medicine Communications

Volumn 27, Issue 10, 2006, Pages 815-821

  Roelants, Véronique ^a   Bernard, Xavier ^b   Walrand, Stephan ^a   Bol, Anne ^a   Coppens, Ann ^a   Jamart, Jacques ^a   Melin, Jacques ^a,c   Vanoverschelde, Jean Louis ^a,c  

^a Departments of Nuclear Medicine   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Attenuation correction; Myocardial perfusion SPECT; Myocardial PET; Myocardial viability

Indexed keywords

AMMONIA N 13; FLUORODEOXYGLUCOSE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ALGORITHM; ARTICLE; ATTENUATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG UPTAKE; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE; HEART MUSCLE PERFUSION; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; MALE; OBESITY; PHOTON EMISSION TOMOGRAPHY; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ALGORITHMS; CORONARY CIRCULATION; ECHOCARDIOGRAPHY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; ISCHEMIA; MYOCARDIUM; OVERWEIGHT; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33748754261     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/01.mnm.0000237985.23973.fb     Document Type: Article

References (38)

1. Wackers FJ. Artifacts in planar and SPECT myocardial perfusion imaging. Am J Cardiol Imaging 1992; 6:42-57.
2. Hayes SW, De Lorenzo A, Hachamovitch R, Dhar S, Hsu P, Cohen I, et al. Prognostic implications of combined prone and supine acquisitions in patients with equivocal or abnormal supine myocardial perfusion SPECT. J Nucl Med 2003; 44:1633-1640.
3. DePuey EG, Rozanski A. Using gated technetium-99m-sestamibi SPECT to characterize fixed myocardial defects as infarct or artifact. J Nucl Med 1995; 36:952-955.
4. Heller GV, Links J, Bateman TM, Ziffer JA, Ficaro E, Cohen MC, Hendel RC. American Society of Nuclear Cardiology and Society of Nuclear Medicine joint position statement: attenuation correction of myocardial perfusion SPECT scintigraphy. J Nucl Cardiol 2004; 11:229-230.
5. Prvulovich EM, Lonn AH, Bomanji JB, Jarritt PH, Ell PJ. Effect of attenuation correction on myocardial thallium-201 distribution in patients with a low likelihood of coronary artery disease. Eur J Nucl Med 1997; 24:266-275.
6. Araujo LI, Jiminez-Hoyuela JM, McClellan JR, Lin E, Viggiano J, Alavi A. Improved uniformity in tomographic myocardial perfusion imaging with attenuation correction and enhanced acquisition and processing. J Nucl Med 2000; 41:1139-1144.
7. Grossman GB, Garcia EV, Bateman TM, Heller GV, Johnson LL, Folks RD, et al. Quantitative Tc-99m sestamibi attenuation-corrected SPECT: development and multicenter trial validation of myocardial perfusion stress gender-independent normal database in an obese population. J Nucl Cardiol 2004; 11:263-272.
8. Kjaer A, Cortsen A, Rahbek B, Hasseldam H, Hesse B. Attenuation and scatter correction in myocardial SPET: improved diagnostic accuracy in patients with suspected coronary artery disease. Eur J Nucl Med Mol Imaging 2002; 29:1438-1442.
9. Banzo I, Pena FJ, Allende RH, Quirce R, Carril JM. Prospective clinical comparison of non-corrected and attenuation- and scatter-corrected myocardial perfusion SPECT in patients with suspicion of coronary artery disease. Nucl Med Commun 2003; 24:995-1002.
10. Thompson RC, Heller GV, Johnson LL, Case JA, Cullom SJ, Garcia EV, et al. Value of attenuation correction on ECG-gated SPECT myocardial perfusion imaging related to body mass index. J Nucl Cardiol 2005; 12:195-202.
11. Gallowitsch HJ, Unterweger O, Mikosch P, et al. Attenuation correction improves the detection of viable myocardium by thallium-201 cardiac tomography in patients with previous myocardial infarction and left ventricular dysfunction. Eur J Nucl Med 1999; 26:459-466.
12. 18F-fluorodeoxyglucose. J Am Coll Cardiol 1998; 32:927-935.
13. Slart RH, Bax JJ, Sluiter WJ, van Veldhuisen DJ, Jager PL. Added value of attenuation-corrected Tc-99m tetrofosmin SPECT for the detection of myocardial viability: comparison with FDG SPECT. J Nucl Cardiol 2004; 11:689-696.
14. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237:E214-E223.
15. Knuuti MJ, Nuutila P, Ruotsalainen U, et al. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. J Nucl Med 1992; 33:1255-1262.
16. Walrand SH, van Elmbt LR, Pauwels S. A non-negative fast multiplicative algorithm in 3D scatter-compensated SPET reconstruction. Eur J Nucl Med 1996; 23:1521-1526.
17. Daube-Witherspoon ME, Muehllehner G. An iterative image space reconstruction algorithm suitable for volume ECT. IEEE Trans Med Imaging 1986; 5:61-66.
18. De Pierro AR. On the convergence of the iterative image space reconstruction algorithm for volume ECT. IEEE Trans Med Imaging 1987; 6:174-175.
19. Sibomana M, Coppens A, Lonneux M, Gerber B, De Volder A, Blin J, et al. Volumic Image Analysis Application Bundle for Unix Workstations. IEEE Medical Imaging Conference; 1995, pp. 1488-1992.
20. American Society of Echocardiography Committee on Standards: subcommittee on quantitation of two-dimensional echocardiograms. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989; 2:58-67.
21. Coppens A, Sibomana M, Bol A, Michel C. MEDIMAN, An object oriented approach for medical image analysis. IEEE Trans Nucl Sci 1993; 40:950-955.
22. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73:13-22.
23. Davis CH. A computer program for regression analysis of repeated measures using generalized estimating equations. Comput Methods Programs Biomed 1993; 40:15-31.
24. 99mTc-sestamibi single- photon emission computed tomography. Circulation 1996; 93:463-473.
25. Kluge R, Sattler B, Seese A, Knapp WH. Attenuation correction by simultaneous emission-transmission myocardial single-photon emission tomography using a technetium-99m-labelled radiotracer: impact on diagnostic accuracy. Eur J Nucl Med 1997; 24:1107-1114.
26. 201Tl myocardial perfusion images. J Nucl Med 1999; 40:1301-1309.
27. Matsunari I, Boning G, Ziegler SI, et al. Attenuation-corrected rest thallium-201/stress technetium 99m sestamibi myocardial SPECT in normals. J Nucl Cardiol 1998; 5:48-55.
28. Hendel RC, Berman DS, Cullom SJ, et al. Multicenter clinical trial to evaluate the efficacy of correction for photon attenuation and scatter in SPECT myocardial perfusion imaging. Circulation 1999; 99:2742-2749.
29. Gallowitsch HJ, Sykora J, Mikosch P, et al. Attenuation-corrected thallium-201 single-photon emission tomography using a gadolinium-153 moving line source: clinical value and the impact of attenuation correction on the extent and severity of perfusion abnormalities. Eur J Nucl Med 1998; 25:220-228.
30. Masood Y, Liu YH, Depuey G, Taillefer R, Araujo LI, Allen S, et al. Clinical validation of SPECT attenuation correction using x-ray computed tomography-derived attenuation maps: multicenter clinical trial with angiographic correlation. J Nucl Cardiol 2005; 12:676-686.
31. Corbett JR, Ficaro EP. Clinical review of attenuation-corrected cardiac SPECT. J Nucl Cardiol 1999; 6:54-68.
32. Fricke E, Fricke H, Weise R, Kammeier A, Hagedorn R, Lotz N, et al. Attenuation correction of myocardial SPECT perfusion images with low-dose CT: evaluation of the method by comparison with perfusion PET. J Nucl Med 2005; 46:736-744.
33. Soufer R, Dey HM, Ng CK, Zaret BL. Comparison of sestamibi single-photon emission computed tomography with positron emission tomography for estimating left ventricular myocardial viability. Am J Cardiol 1995; 15:1214-1219.
34. Slart RH, Bax JJ, Sluiter WJ, van Veldhuisen DJ, Jager PL. Added value of attenuation-corrected Tc-99m tetrofosmin SPECT for the detection of myocardial viability: comparison with FDG SPECT. J Nucl Cardiol 2004; 11:689-696.
35. Vom DJ, Altehoefer C, Sheehan FH, et al. Recovery of regional left ventricular dysfunction after coronary revascularization. Impact of myocardial viability assessed by nuclear imaging and vessel patency at follow-up angiography. J Am Coll Cardiol 1996; 28:948-958.
36. 99mTc sestamibi SPECT. J Nucl Cardiol 1998; 5:4-13.
37. Bax JJ, Visser FC, Poldermans D, Elhendy A, Cornel JH, Boersma E, et al. Time course of functional recovery of stunned and hibernating segments after surgical revascularization. Circulation 2001; 104:1314-1318.
38. Desideri A, Cortigiani L, Christen AI, Coscarelli S, Gregori D, Zanco P, et al. The extent of perfusion-F18-fluorodeoxyglucose positron emission tomography mismatch determines mortality in medically treated patients with chronic ischemic left ventricular dysfunction. J Am Coll Cardiol 2005; 46:1264-1269.